Association Between Anaemia and Handgrip Strength in Female Planned for Major Surgery and the Effect of Intravenous Iron on Handgrip Strength
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04642521 |
|
Recruitment Status :
Not yet recruiting
First Posted : November 24, 2020
Last Update Posted : November 24, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
This is a sub-study parallel to ProPBM : A Randomised Control Trial Comparing a Modified Patient Blood Management Protocol Against Standard Care for Patients Undergoing Major Surgery (NCT03888768).
Only female participants of ProPBM will be included in this sub-study.
Association between anaemia and handgrip strength and the effect of intravenous iron therapy as part of ProPBM protocol within female participants is elucidated in this study.
| Condition or disease | Intervention/treatment |
|---|---|
| Anemia Iron-deficiency Patient Blood Management Iron Deficiency Anemia | Device: Jamar hydraulic hand dynamometer |
BACKGROUND:
Maximal physical efforts and aerobic exercise depend highly on adequate oxygen supply provided by haemoglobin and level of iron bound to haemoglobin.
Handgrip strength has been shown to have a strong validity and high reliability in testing the upper body and lower body muscle strength, however its use as a potential tool to identify early anaemic patients planned for surgery is not fully explored. To our knowledge, this study is the first to investigate the diagnostic power of functional performance test within preoperative anaemic population and the change of handgrip strength after administration of intravenous iron.
METHODS:
At recruitment of ProPBM study, all eligible patients for this sub-study will be invited to this sub-study and have their full blood count, ferritin and transferrin saturation recorded and handgrip strength assessed.
After randomization, those within the ProPBM protocol will receive IV iron therapy as indicated. Participants who are randomized to standard care will follow usual medical management.
Participants will be admitted 1 day prior to surgery. On admission, preoperative bloods and handgrip strength will be repeated for patients who were randomized into the ProPBM arm.
| Study Type : | Observational |
| Estimated Enrollment : | 65 participants |
| Observational Model: | Case-Control |
| Time Perspective: | Prospective |
| Official Title: | Anaemia and Handgrip Strength, a Prospective Observatonal Study Amongst Female Population Planned for Major Elective Surgery |
| Estimated Study Start Date : | November 18, 2020 |
| Estimated Primary Completion Date : | March 31, 2021 |
| Estimated Study Completion Date : | April 30, 2021 |
| Group/Cohort | Intervention/treatment |
|---|---|
|
Iron deficiency anaemia
Preoperatively, participants who are iron deficient with or without anaemia will receive intravenous iron (Monofer) as per ProPBM protocol.
|
Device: Jamar hydraulic hand dynamometer
The strength of the dominant hand will be recorded before and after receiving intravenous iron. Each participant will be positioned in a straight back chair with both hand and feet flat on the ground, elbow flexed to 90 degrees with forearm and wrist in the neutral position. Patient's muscle strength will then be tested three times with an interval of one minute between testing and the average of three times will be recorded to the nearest 0.1kg. Other Name: Handgrip strength |
|
No iron deficiency anaemia
Patient in this group will not be given intravenous iron.
|
Device: Jamar hydraulic hand dynamometer
The strength of the dominant hand will be recorded before and after receiving intravenous iron. Each participant will be positioned in a straight back chair with both hand and feet flat on the ground, elbow flexed to 90 degrees with forearm and wrist in the neutral position. Patient's muscle strength will then be tested three times with an interval of one minute between testing and the average of three times will be recorded to the nearest 0.1kg. Other Name: Handgrip strength |
- Association between handgrip strength and haemoglobin status within female participants of ProPBM study [ Time Frame: At recruitment ]
The dependent variable is concentration of plasma circulating haemoglobin (Hb) taken at recruitment and measured in g/dL.
The non-dependant variable is the baseline handgrip strength recorded in kilogram using Jamar hydraulic hand dynamometer. Participants will be positioned in a straight back chair with both hand and feet flat on the ground, elbow flexed to 90 degrees with forearm and wrist in the neutral position. Patient's muscle strength will then be tested three times with an interval of one minute between testing and the average of three times will be recorded to the nearest 0.1kg.
The association between anaemia and handgrip strength will be analyzed by using binary logistic regression technique.
- Association between handgrip strength and iron status within female participants of ProPBM study [ Time Frame: At recruitment ]
Iron status is measured by ferritin level (mcg/L) and transferrin saturation (percentage value).
Association between iron status and handgrip strength will be analysed using a linear regression technique.
- Change in handgrip strength in iron deficient female participants of ProPBM study who received intravenous iron [ Time Frame: Handgrip strength repeated within 1 month post IV iron administration preoperatively ]
Participants who received intravenous iron will have their ferritin level, TSAT and handgrip strength reassesed during preoperative admission.
Handgrip strength after IV iron administration will be compared to baseline handgrip strength.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 80 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | Female |
| Gender Based Eligibility: | Yes |
| Gender Eligibility Description: | Female population |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Female patients participating in the ProPBM study
- Undergoing major surgery in gynaecology, gastrointestinal surgery and orthopaedics surgery
- The patient must be willing and able to provide informed consent for the study
Exclusion Criteria:
- Patients with known muscle weakness eg myasthenia gravis
- Patients with cerebrovascular or orthopaedic disease that could influence muscle mass and/or upper body function
- Patients in which IV iron is contraindicated eg 1st trimester of pregnancy or known allergy or hypersensitivity to parenteral iron
- Patients with iron overload
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04642521
| Contact: University of Malaya Medical Centre Jalan Universiti | +60379494422 | ummc@ummc.edu.my |
| Malaysia | |
| University Malaya Medical Centre | |
| Kuala Lumpur, Malaysia, 59100 | |
| Contact: Nurafza Ahmad Hisham +60124100029 nurafza@gmail.com | |
| Sub-Investigator: Nurafza Ahmad Hisham | |
| Principal Investigator: Ina I Shariffuddin | |
| Principal Investigator: | Ina I Shariffuddin | Ministry of Health, Malaysia |
Other Publications:
| Responsible Party: | University of Malaya |
| ClinicalTrials.gov Identifier: | NCT04642521 |
| Other Study ID Numbers: |
Anaemiahandgrip |
| First Posted: | November 24, 2020 Key Record Dates |
| Last Update Posted: | November 24, 2020 |
| Last Verified: | November 2020 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Plan Description: | Study protocol, statistic analysis plan |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
handgrip strength intravenous iron |
|
Anemia Anemia, Iron-Deficiency Hematologic Diseases |
Anemia, Hypochromic Iron Metabolism Disorders Metabolic Diseases |

